Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jacobson

Showing results (591-600 of 677) with videos related to

Pageof 68
Sort By:
Investigative Ophthalmology & Visual Science|January 27, 2005
Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotypeSharon B Schwartz, Tomas S Aleman, Artur V Cideciyan, et al.
Plos Medicine|June 28, 2007
Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutationGeoffrey K Aguirre, András M Komáromy, Artur V Cideciyan, et al.
Human Molecular Genetics|October 5, 2012
Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutantsSamuel G Jacobson, Artur V Cideciyan, Igor V Peshenko, et al.
Cell Reports|July 13, 2017
In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 MutationsHiroko Shimada, Quanlong Lu, Christine Insinna-Kettenhofen, et al.
Human Gene Therapy|July 9, 2009
Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 yearArtur V Cideciyan, William W Hauswirth, Tomas S Aleman, et al.
American Journal of Human Genetics|November 1, 1996
Myosin VIIA mutation screening in 189 Usher syndrome type 1 patientsM D Weston, P M Kelley, L D Overbeck, et al.
Human Gene Therapy|July 8, 2010
Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in IsraelEyal Banin, Dikla Bandah-Rozenfeld, Alexey Obolensky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
In utero gene therapy rescues vision in a murine model of congenital blindnessNadine S Dejneka, Enrico M Surace, Tomas S Aleman, et al.
Plos One|March 28, 2014
Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapyShannon E Boye, Wei-Chieh Huang, Alejandro J Roman, et al.
International Journal of Epidemiology|June 22, 2023
Cohort Profile Update: The US Millennium Cohort Study-evaluating the impact of military experiences on service members and veteran healthSheila F Castañeda, Jennifer N Belding, Claire A Kolaja, et al.
Pageof 68

Showing results (591-600 of 677) with videos related to

Sort By:
Pageof 68
Investigative Ophthalmology & Visual Science|January 27, 2005
Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotypeSharon B Schwartz, Tomas S Aleman, Artur V Cideciyan, et al.
Plos Medicine|June 28, 2007
Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutationGeoffrey K Aguirre, András M Komáromy, Artur V Cideciyan, et al.
Human Molecular Genetics|October 5, 2012
Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutantsSamuel G Jacobson, Artur V Cideciyan, Igor V Peshenko, et al.
Cell Reports|July 13, 2017
In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 MutationsHiroko Shimada, Quanlong Lu, Christine Insinna-Kettenhofen, et al.
Human Gene Therapy|July 9, 2009
Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 yearArtur V Cideciyan, William W Hauswirth, Tomas S Aleman, et al.
American Journal of Human Genetics|November 1, 1996
Myosin VIIA mutation screening in 189 Usher syndrome type 1 patientsM D Weston, P M Kelley, L D Overbeck, et al.
Human Gene Therapy|July 8, 2010
Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in IsraelEyal Banin, Dikla Bandah-Rozenfeld, Alexey Obolensky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
In utero gene therapy rescues vision in a murine model of congenital blindnessNadine S Dejneka, Enrico M Surace, Tomas S Aleman, et al.
Plos One|March 28, 2014
Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapyShannon E Boye, Wei-Chieh Huang, Alejandro J Roman, et al.
International Journal of Epidemiology|June 22, 2023
Cohort Profile Update: The US Millennium Cohort Study-evaluating the impact of military experiences on service members and veteran healthSheila F Castañeda, Jennifer N Belding, Claire A Kolaja, et al.
Pageof 68